Cancer
Cancer Ongoing 2021 North Shore NSW

ASCOLT

To assess the effectiveness of Aspirin against placebo control in patients with dukes C or high risk dukes B colorectal cancer in terms of Disease Free Survival (DFS) and Overall Survival (OS).

Trial overview

Disease
Colorectal cancer
Topic
ASCOLT
Description
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial
Eligibility criteria

Dukes C and High Risk Dukes B Colorectal Cancer.

Study details

This study is investigating if daily aspirin improves the outcomes for patients treated curatively for colorectal cancer.

Further information

For more information regarding this clinical trial click here.

Location

North Shore NSW